Advertisement

Efficacy and Safety of Gabapentin on Postoperative Pain Management After Bariatric Surgery: A Systematic Review and Meta-Analysis

Published:November 19, 2022DOI:https://doi.org/10.1016/j.jopan.2022.04.017

      Abstract

      Purpose

      Examine the efficacy and safety of perioperative gabapentin in bariatric surgical patients.

      Design

      Systematic Review and Meta-analysis.

      Methods

      An exhaustive search was conducted using PubMed, Cochrane Library, MEDLINE, CINAHL, Google Scholar, and other gray literature. Only randomized controlled trials evaluating the use of gabapentin in bariatric surgery were included. Risk ratio (RR) and mean difference (MD) were used to estimate outcomes with suitable effect models. Quality of evidence was assessed using the Risk of Bias and GRADE system.

      Findings

      Four trials consisting of 283 patients were analyzed. The use of gabapentin significantly lowered the cumulative pain score in the first 24 hours after surgery by an average of 1.04 (MD, –1.04; 95% CI, –1.45 to –0.63; P < .00001). Gabapentin also reduced the overall morphine equivalent consumption by 7.89 mg (MD, –7.89; 95% CI, –13.56 to –2.2; P = .006). However, gabapentin did not affect the incidence of PONV (RR, 0.61; 95% CI, 0.38-1.00; P = .05), somnolence (RR, 1.25; 95% CI, 0.57-2.73; P = .57), dizziness (RR, 1.01; 95% CI, 0.40-2.54; P = .99), and headache (RR, 0.76; 95% CI, 0.25-2.30; P = .62). Substantial heterogeneity, imprecision of the effect size, and potential publication bias were limitations of this review.

      Conclusion

      The use of gabapentin is effective in the management of postoperative pain in bariatric surgery. However, there is limited data regarding the opioid-sparing effect and adverse effect profiles of gabapentin in the bariatric surgical population.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of PeriAnesthesia Nursing
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gan T.
        Poorly controlled postoperative pain: prevalence, consequences, and prevention.
        J Pain Res. 2017; 10: 2287-2298https://doi.org/10.2147/jpr.s144066
        • Apfelbaum J
        • Chen C
        • Mehta S
        • Gan A
        Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged.
        Anesth Analg. 2003; 97: 534-540https://doi.org/10.1213/01.ane.0000068822.10113.9e
        • Gan T
        • Habib A
        • Miller T
        • White W
        • Apfelbaum J.
        Incidence, patient satisfaction, and perceptions of post-surgical pain: results from a US national survey.
        Curr Med Res Opin. 2013; 30: 149-160https://doi.org/10.1185/03007995.2013.860019
        • Lloret-Linares C
        • Lopes A
        • Declèves X
        • et al.
        Challenges in the optimisation of post-operative pain management with opioids in obese patients: a literature review.
        Obes Surg. 2013; 23: 1458-1475https://doi.org/10.1007/s11695-013-0998-8
        • Gamboa J
        • Nunez D.
        Pain management in weight loss surgery: aiming for multimodal approach.
        Adv Obes Weight Manag Control. 2016; 5https://doi.org/10.15406/aowmc.2016.05.00125
        • Telessy I
        • Buttar H.
        Obesity-related alterations in pharmacokinetics and pharmacodynamics of drugs: emerging clinical implications in obese patients - part I.
        Adipobiology. 2018; 9: 29https://doi.org/10.14748/adipo.v9.4989
        • Telessy I
        • Buttar H.
        Obesity related alterations in pharmacokinetics and pharmacodynamics of drugs: emerging clinical implications in obese patients - part II.
        Adipobiology. 2018; 9: 39https://doi.org/10.14748/adipo.v9.4990
        • Hah J
        • Mackey S
        • Schmidt P
        • et al.
        Effect of perioperative gabapentin on postoperative pain resolution and opioid cessation in a mixed surgical cohort.
        JAMA Surg. 2018; 153: 303https://doi.org/10.1001/jamasurg.2017.4915
        • Qadeer M
        • Waqas M
        • Rashid M
        • Enam S
        • Sharif S
        • Murtaza G.
        Preventive gabapentin versus pregabalin to decrease postoperative pain after lumbar microdiscectomy: a randomized controlled trial.
        Asian Spine J. 2017; 11: 93-98https://doi.org/10.4184/asj.2017.11.1.93
        • Nakhli M
        • Kahloul M
        • Jebali C
        • Frigui W
        • Naija W.
        Effects of gabapentinoids premedication on shoulder pain and rehabilitation quality after laparoscopic cholecystectomy: pregabalin versus gabapentin.
        Pain Res Manag. 2018; 2018: 1-6https://doi.org/10.1155/2018/9834059
        • Routray S
        • Pani N
        • Mishra D
        • Nayak S.
        Comparison of pregabalin with gabapentin as preemptive analgesic in lumbar spine surgery.
        J Anaesthesiol Clin Pharmacol. 2018; 34: 232-236https://doi.org/10.4103/joacp.JOACP_12_17
        • Wiffen P
        • Derry S
        • Bell R
        • et al.
        Gabapentin for chronic neuropathic pain in adults.
        Cochrane Database Syst Rev. 2017; 2020https://doi.org/10.1002/14651858.cd007938.pub4
        • Chincholkar M.
        Analgesic mechanisms of gabapentinoids and effects in experimental pain models: a narrative review.
        Br J Anaesth. 2018; 120: 1315-1334https://doi.org/10.1016/j.bja.2018.02.066
        • Peckham A
        • Evoy K
        • Ochs L
        • Covvey J.
        Gabapentin for off-label use: evidence-based or cause for concern?.
        Subst Abuse. 2018; 12117822181880131https://doi.org/10.1177/1178221818801311
        • Verret M
        • Lauzier F
        • Zarychanski R
        • et al.
        Perioperative use of gabapentinoids for the management of postoperative acute pain.
        Anesthesiology. 2020; 133: 265-279https://doi.org/10.1097/aln.0000000000003428
        • Liu B
        • Liu R
        • Wang L.
        A meta-analysis of the preoperative use of gabapentinoids for the treatment of acute postoperative pain following spinal surgery.
        Medicine (Baltimore). 2017; 96: e8031https://doi.org/10.1097/md.0000000000008031
        • Peng P
        • Wijeysundera D
        • Li C.
        Use of gabapentin for perioperative pain control – a meta-analysis.
        Pain Res Manag. 2007; 12: 85-92https://doi.org/10.1155/2007/840572
        • Peng C
        • Li C
        • Qu J
        • Wu D.
        Gabapentin can decrease acute pain and morphine consumption in spinal surgery patients.
        Medicine (Baltimore). 2017; 96: e6463https://doi.org/10.1097/md.0000000000006463
        • Han C
        • Li X
        • Jiang H
        • Ma J
        • Ma X.
        The use of gabapentin in the management of postoperative pain after total knee arthroplasty.
        Medicine (Baltimore). 2016; 95: e3883https://doi.org/10.1097/md.0000000000003883
        • Tsaousi G
        • Logan S
        • Bilotta F.
        Postoperative pain control following craniotomy: a systematic review of recent clinical literature.
        Pain Pract. 2017; 17: 968-981https://doi.org/10.1111/papr.12548
        • Li X
        • Han C
        • Yu W.
        Is gabapentin effective and safe in open hysterectomy? A PRISMA compliant meta-analysis of randomized controlled trials.
        J Clin Anesth. 2017; 41: 76-83https://doi.org/10.1016/j.jclinane.2017.07.002
        • Wang L
        • Dong Y
        • Zhang J
        • Tan H.
        The efficacy of gabapentin in reducing pain intensity and postoperative nausea and vomiting following laparoscopic cholecystectomy.
        Medicine (Baltimore). 2017; 96: e8007https://doi.org/10.1097/md.0000000000008007
        • Page MJ
        • McKenzie JE
        • Bossuyt PM
        • et al.
        The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
        BMJ. 2021; 372: n71https://doi.org/10.1136/bmj.n71
      1. Higgins JPT Thomas J Chandler J Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021
        www.training.cochrane.org/handbook
        Date accessed: December 5, 2021
        • Ryan R
        • Hill S
        How to GRADE the Quality of the Evidence.
        Cochrane Consumers and Communication Group, 2016
        http://cccrg.cochrane.org/author-resources
        Date accessed: December 5, 2021
        (Version 3.0 December 2016)
      2. Opioid Oral Morphine Milligram Equivalent (MME) Conversion Factors.
        2022 (Medicaid.utah.gov) (PublishedAccessed January 10, 2022)
        • Wan X
        • Wang W
        • Liu J
        • Tong T.
        Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range.
        BMC Med Res Methodol. 2014; 14: 135https://doi.org/10.1186/1471-2288-14-135
        • Rohatgi A
        WebPlotDigitizer.
        WebPlotDigitizer, 2011
        http://arohatgi.info/WebPlotDigitizer/
        Date accessed: December 18, 2021
        • Khan M
        • Bamehriz F
        • Aqil M
        • Dammas F
        • Fadin A
        • Khokhar R.
        The effect of gabapentin on postoperative pain, morphine sparing effect and preoperative anxiety in patients going for sleeve gastrectomy surgical procedure.
        J Coll Physicians Surg Pak. 2019; 29: 697-701https://doi.org/10.29271/jcpsp.2019.08.697
        • Rupniewska-Ladyko A
        • Malec-Milewska M
        • Kraszewska E
        • Pirozynski M.
        Gabapentin before laparoscopic sleeve gastrectomy reduces postoperative oxycodone consumption in obese patients: a randomized double-blind placebo-controlled trial.
        Minerva Anestesiol. 2018; 84https://doi.org/10.23736/s0375-9393.17.12194-2
        • Abd El-Maksouda K
        • Younes M
        • Elokda S
        Effect of preoperative pregabalin versus gabapentin on postoperative pain control after laparoscopic gastric bypass surgery.
        Ain-Shams J Anaesthesiol. 2017; 10: 195-200
        • Hassani V
        • Pazouki A
        • Nikoubakht N
        • Chaichian S
        • Sayarifard A
        • Shakib khankandi A
        The effect of gabapentin on reducing pain after laparoscopic gastric bypass surgery in patients with morbid obesity: a randomized clinical trial.
        Anesth Pain Med. 2015; 5https://doi.org/10.5812/aapm.22372
        • Hales CM
        • Carroll MD
        • Fryar CD
        • Ogden CL.
        Prevalence of obesity and severe obesity among adults: United States, 2017-2018.
        NCHS Data Brief. 2020; : 1-8
        • American Society for Metabolic and Bariatric Surgery
        New Study Finds Most Bariatric Surgeries Performed in Northeast, and Fewest in South Where Obesity Rates are Highest, and Economies are Weakest.
        2022 (PublishedAccessed January 29, 2022)
        • Center for Disease Control and Prevention
        Obesity is a Common, Serious, and Costly Disease.
        2022 (PublishedAccessed January 29, 2022)
        • Peromaa-Haavisto P
        • Tuomilehto H
        • Kössi J
        • et al.
        Prevalence of obstructive sleep apnoea among patients admitted for bariatric surgery. A prospective multicentre trial.
        Obes Surg. 2016; 26: 1384-1390https://doi.org/10.1007/s11695-015-1953-7
        • Horsley R
        • Vogels E
        • McField D
        • et al.
        Multimodal postoperative pain control is effective and reduces opioid use after laparoscopic Roux-en-Y gastric bypass.
        Obes Surg. 2019; 29: 394-400https://doi.org/10.1007/s11695-018-3526-z
        • Olsen M
        • Bjerre E
        • Hansen M
        • et al.
        Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain.
        BMC Med. 2017; 15https://doi.org/10.1186/s12916-016-0775-3
        • Chincholkar M.
        Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice.
        Br J Pain. 2020; 14: 104-114https://doi.org/10.1177/2049463720912496
        • Desai P
        • Taylor O
        • Shah K
        • Evoy K
        • Peckham A.
        Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids.
        Ment Health Clin. 2021; 11: 225-230https://doi.org/10.9740/mhc.2021.07.225
        • Nelson G
        • Dowdy S
        • Lasala J
        • et al.
        Enhanced recovery after surgery (ERAS®) in gynecologic oncology – practical considerations for program development.
        Gynecol Oncol. 2017; 147: 617-620https://doi.org/10.1016/j.ygyno.2017.09.023
        • Leech J
        • Oswalt K
        • Tucci M
        • Alam Mendez O
        • Hierlmeier B
        Opioid sparing anesthesia and enhanced recovery after surgery protocol for pancreaticoduodenectomy.
        Cureus. 2021; https://doi.org/10.7759/cureus.19558
        • Siddiqui N
        • Yousefzadeh A
        • Yousuf M
        • Kumar D
        • Choudhry F
        • Friedman Z.
        The effect of gabapentin on delayed discharge from the postanesthesia care unit: a retrospective analysis.
        Pain Pract. 2017; 18: 18-22https://doi.org/10.1111/papr.12575